$4.88
0.68[16.19%]
At close: Apr 26
$4.88
0[0.00%]
After Hours: 6:07PM EDT
Ocular Therapeutix
(NASDAQ:OCUL)Latest News for Ocular Therapeutix Stock (NASDAQ:OCUL)
Ocular Therapeutix Stock (NASDAQ: OCUL)
Categories: All
Friday, April 19, 2024
Thursday, April 18, 2024
- Ocular Therapeutix Highlights Early Data From Diabetes-Related Eye DisorderVandana Singh - Apr 18, 2024, 1:37PM
- Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Apr 18, 2024, 11:32AM
- Ocular Therapeutix shares are trading lower. The company announced topline results from the Phase 1 HELIOS study evaluating AXPAXLI in patients with moderately severe to severe non-proliferative diabetic retinopathy.Benzinga Newsdesk - Apr 18, 2024, 11:31AM
- Ocular Therapeutix Reports Topline Phase 1 Data For AXPAXLI In Diabetic Retinopathy; AXPAXLI Was Generally Well Tolerated With No Inflammation ObservedBenzinga Newsdesk - Apr 18, 2024, 7:03AM
Tuesday, April 16, 2024
Monday, April 08, 2024
Wednesday, March 13, 2024
- JMP Securities Reiterates Market Outperform on Ocular Therapeutix, Maintains $24 Price TargetBenzinga Newsdesk - Mar 13, 2024, 11:34AM
- Decoding 6 Analyst Evaluations For Ocular TherapeutixBenzinga Insights - Mar 13, 2024, 8:01AM
- HC Wainwright & Co. Maintains Buy on Ocular Therapeutix, Raises Price Target to $15Benzinga Newsdesk - Mar 13, 2024, 6:46AM
Tuesday, March 12, 2024
- Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionAvi Kapoor - Mar 12, 2024, 2:07PM
- These Analysts Boost Their Forecasts On Ocular Therapeutix After Q4 ResultsAvi Kapoor - Mar 12, 2024, 12:42PM
- TD Cowen Maintains Market Perform on Ocular Therapeutix, Raises Price Target to $11Benzinga Newsdesk - Mar 12, 2024, 11:53AM
- JMP Securities Maintains Market Outperform on Ocular Therapeutix, Raises Price Target to $24Benzinga Newsdesk - Mar 12, 2024, 10:10AM
- Why Oracle Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 12, 2024, 8:11AM
- ACADIA Pharmaceuticals, Ocular Therapeutix, Asana And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionAvi Kapoor - Mar 12, 2024, 5:36AM
Monday, March 11, 2024
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga Insights - Mar 11, 2024, 5:34PM
- Ocular Therapeutix shares are trading lower after the company reported worse-than-expected Q4 financial results.Benzinga Newsdesk - Mar 11, 2024, 4:43PM
- Ocular Therapeutix: Q4 Earnings InsightsBenzinga Insights - Mar 11, 2024, 4:15PM
- Ocular Therapeutix Q4 2023 GAAP EPS $(0.35) Misses $(0.30) Estimate, Sales $14.802M Miss $15.707M EstimateBenzinga Newsdesk - Mar 11, 2024, 4:12PM
- Why Fangdd Network Group Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Mar 11, 2024, 8:08AM
- Earnings Scheduled For March 11, 2024Benzinga Insights - Mar 11, 2024, 4:56AM
Friday, March 08, 2024
Wednesday, February 28, 2024
Monday, February 26, 2024
Thursday, February 22, 2024
- Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Feb 22, 2024, 1:37PM
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - Feb 22, 2024, 12:31PM
- NICE Posts Upbeat Earnings, Joins FTI Consulting, NVIDIA, Moderna And Other Big Stocks Moving Higher On ThursdayAvi Kapoor - Feb 22, 2024, 11:33AM
- Ocular Therapeutix shares are trading higher after the company announced a $325 million private placement.Benzinga Newsdesk - Feb 22, 2024, 10:47AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Feb 22, 2024, 8:05AM
- Ocular Therapeutix Announces $325M Private Placement Of 32,413,560 Shares At $7.52/Share And 10,805,967 Pre-Funded Warrants At $7.519/WarrantBenzinga Newsdesk - Feb 22, 2024, 7:33AM
Wednesday, February 14, 2024
Tuesday, February 13, 2024
Friday, February 09, 2024
- Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day SessionAvi Kapoor - Feb 9, 2024, 1:18PM
- SPS Commerce Posts Upbeat Results, Joins Masonite International, Impinj And Other Big Stocks Moving Higher On FridayAvi Kapoor - Feb 9, 2024, 10:31AM
- B of A Securities Initiates Coverage On Ocular Therapeutix with Buy Rating, Announces Price Target of $15Benzinga Newsdesk - Feb 9, 2024, 7:24AM
Thursday, January 25, 2024
- Ocular Therapeutix shares are trading higher after the company announced the FDA agreed to a Special Protocol Assessment Agreement Modification for its pivotal Phase 3 SOL clinical trial of AXPAXLI in wet AMD.Benzinga Newsdesk - Jan 25, 2024, 1:48PM
- Ocular Therapeutix Announces FDA Agreement To Amend Special Protocol Assessment For Pivotal Clinical Trial Of AXPAXLI In Wet AMD; SPA Amendment Expands Eligibility Criteria For SOL Clinical TrialBenzinga Newsdesk - Jan 25, 2024, 8:05AM
Thursday, December 14, 2023
- Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionAvi Kapoor - Dec 14, 2023, 12:56PM
- Ocular Therapeutix shares are trading lower after the company announced pricing of a public offering of common stock.Benzinga Newsdesk - Dec 14, 2023, 9:04AM
- Why Nxu Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving PremarketAvi Kapoor - Dec 14, 2023, 8:27AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Dec 14, 2023, 8:07AM
- Adobe Issues Weak Forecast, Joins Mueller Water Products, AerSale And Other Big Stocks Moving Lower In Thursday's Pre-Market SessionAvi Kapoor - Dec 14, 2023, 5:44AM
- Ocular Therapeutix Prices Public Offering Of 30.8M Common Share Stock At $3.25/Share For Gross Proceeds Of $100.1MBenzinga Newsdesk - Dec 14, 2023, 2:23AM